Trump Media and Technology Group Corp vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Trump Media and Technology Group Corp trades at $8.11 (market cap $2.28B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 2.6× Trump Media and Technology Group Corp's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Trump Media and Technology Group Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Trump Media and Technology Group Corp for 17 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| DJT | IOVA | |
|---|---|---|
Market Cap | $2.28B | $6.04B |
Volume | 3,148,379 | 14,805,993 |
Sector | Media | Health |
52-Week High | $16.56 | $14.82 |
52-Week Low | $7.06 | $1.81 |
Typical Hold Time | 17 Days | 0 Days |
Enterprise Value | $2.35B | $5.97B |
Signals from Pluang's Aura AI — not financial advice
DJT trades at $8.20, down 0.24% with a bearish technical signal. The company reported minimal revenue of $3.68 million for 2025 but posted a substantial net loss of $712 million, resulting in negative profit margins. Recent news highlights a proposed merger with TAE Technologies and ongoing volatility linked to political developments. Cash flow trends show heavy investing outflows partially offset by financing activities.
The outlook remains challenging with persistent losses and high valuation multiples. Investment appeal is limited by weak fundamentals, though merger speculation offers potential upside. Key risks include execution of the TAE merger, sustained negative profitability, and sensitivity to political events. The stock faces pressure from declining institutional interest and insider selling.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Trump Media & Technology Group is a media firm rooted in social media and digital streaming. Its flagship product, Truth Social, provides a platform focused on free speech and open conversation.
Read more on DJT →Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →